Widely used:
Analyst’s Choice
Recently Viewed
Clear All
Value Research Rating
Analyst’s Choice
Riskometer
Very High
₹322.8365 -0.78%
As on 03-Oct-2024
As per SEBI's Riskometer.
Split between different types of investments
Split between categories of Equity investments
Rating |
VR Opinion |
Risk
|
Return (%) |
|
Expense Ratio (%)
|
|
|---|---|---|---|---|---|---|
|
UTI Healthcare Fund - Direct Plan
|
|
|
Very High
|
loading... |
1.29 |
|
 |
|
Very High
|
loading... |
1.07 |
||
 |
|
Very High
|
loading... |
0.90 |
||
|
|
Very High
|
loading... |
0.72 |
||
|
|
Very High
|
loading... |
0.90 |
₹1,168 Cr
1.00 (30)
5,000
--
500
6
Investment Strategy
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Suitability
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.
Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Capital Gains Taxation
Disclaimer: The tax information has been prepared on a best-effort basis using information available in the public domain and other sources that Value Research considers reliable. This is not meant as tax advice, and we advise you to consult your tax advisor before making any decision. Value Research takes no responsibility and assumes no liability for any loss or damage arising from any investment or redemption decision based on this information.
Dividend Taxation
1 min read•By Value Research
1 min read•By Value Research
UTI Healthcare Fund - Direct Plan is mandated to invest at least 80 per cent of its assets in the shares of pharmaceutical and healthcare companies.
Mutual funds can be bought directly from the website of the fund house. For instance, UTI Healthcare Fund - Direct Plan fund can be purchased from the website of UTI Mutual Fund. You can also buy mutual funds through platforms like MF Central, MF Utility, among others. However, if you are not comfortable buying mutual funds online, you can seek help of a mutual fund distributor. Most banks also act as mutual fund distributors. So you can connect with your bank for assistance.
The NAV of UTI Healthcare Fund - Direct Plan is ₹322.8365 as of 04-Oct-2024.
The AUM of UTI Healthcare Fund - Direct Plan Fund is ₹1,168 Cr as of 31-Aug-2024
The riskometer level of UTI Healthcare Fund - Direct Plan is Very High. See More
| Company | Percentage of Portfolio |
|---|---|
|
11.47
|
|
|
6.65
|
|
|
5.56
|
|
|
5.24
|
|
|
3.84
|
As of 31-Aug-2024, UTI Healthcare Fund - Direct Plan had invested 97.48% in Equity, 2.41% in Cash & Cash Eq. and 0.11% in Debt See More
UTI Healthcare Fund - Direct Plan is 11 years 9 months old. It has delivered 17.65% returns since inception. See More
|
1Y
|
3Y
|
5Y
|
7Y
|
10Y
|
Since Inception
|
|---|---|---|---|---|---|
|
57.53%
|
20.18%
|
31.52%
|
20.84%
|
14.47%
|
17.65%
|
No, There is no lock in period in UTI Healthcare Fund - Direct Plan.
The expense ratio of UTI Healthcare Fund - Direct Plan is 1.29.
